Quanterix Corporation (QTRX)

Quanterix Corp (QTRX) is a company that develops and sells tools for biomarker analysis based on its proprietary Simoa technology platform. The company's technology enables researchers and clinicians to detect and measure protein biomarkers with unprecedented sensitivity and precision, which is important for the development of new diagnostic and therapeutic products. Quanterix's products are used in a variety of research areas, including oncology, neurology, infectious disease, and inflammation. The company is headquartered in Billerica, Massachusetts, and was founded in 2007.